Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2.

Jiang, Shu-Heng

Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2. [electronic resource] - FASEB journal : official publication of the Federation of American Societies for Experimental Biology 03 2020 - 3943-3955 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1530-6860

10.1096/fj.201901237R doi


Animals
Cell Line, Tumor
Cell Survival--drug effects
Glucose--metabolism
Glycolysis--drug effects
Hexokinase--metabolism
Humans
Immunohistochemistry
Lactams--pharmacology
Lactic Acid--metabolism
Mice
Mice, Inbred BALB C
Mice, Nude
Real-Time Polymerase Chain Reaction
Surface Plasmon Resonance